Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...

[1] All of these pathophysiologic features are largely represented in asthma, and therefore, anticholinergic drugs have been considered to be of potential interest in the treatment of asthma.

Researchers at National Jewish Health and colleagues have identified a mechanism involved in the formation of mucus plugs in ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

Airsupra (PT027), a new asthma rescue treatment developed by AstraZeneca (AZ) and development partner Avillion, has been approved by the US Food and Drug Administration (FDA). A first-in-class ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more effective than SAMA-only treatment. Details of the study were presented in ...

Asthma is associated with memory problems in children, a new study has found. Further, the early onset of asthma might worsen ...

After some disappointing earlier results for GSK’s new asthma treatment Revlar Ellipta ... to update the drug’s label. The drug is known as Breo Ellipta in the US, and where GSK also ...

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for donidalorsen, an investigational ...